1. Home
  2. ZNB vs TLPH Comparison

ZNB vs TLPH Comparison

Compare ZNB & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.20

Market Cap

37.4M

ML Signal

N/A

TLPH

Talphera Inc.

N/A

Current Price

$0.88

Market Cap

37.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNB
TLPH
Founded
N/A
2005
Country
United States
United States
Employees
14
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
37.9M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ZNB
TLPH
Price
$0.20
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.8M
199.5K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.38
52 Week High
$5.22
$1.57

Technical Indicators

Market Signals
Indicator
ZNB
TLPH
Relative Strength Index (RSI) 32.73 49.20
Support Level $0.19 $0.86
Resistance Level $0.30 $1.03
Average True Range (ATR) 0.03 0.06
MACD 0.01 0.01
Stochastic Oscillator 8.79 55.73

Price Performance

Historical Comparison
ZNB
TLPH

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: